Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

97.89
Delayed Data
As of Feb 05
 -4.04 / -3.96%
Today’s Change
92.98
Today|||52-Week Range
140.72
-18.26%
Year-to-Date

Today’s Trading

Previous close101.93
Today’s open101.72
Day’s range96.40 - 101.94
Volume7,802,324
Average volume (3 months)5,875,439
Market cap$80.1B
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+28.44%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+17.89%
P/E ratio49.1
Price/Sales12.24
Price/Book12.50

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.04+0.05%
AZNAstraZeneca-0.44-1.44%
ABBVAbbVie-3.64-6.41%
NVONovo Nordisk-0.75-1.51%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$1.31
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers